Figure 1
From: Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
(A) Intense membranous immunostaining of carcinoma cells; no stromal immunostaining (E+/S−). (B) Immunostaining of both carcinoma cells and stroma (E+S+). (C) Stromal immunostaining and no epithelial immunostaining (E−S+).
